More Covid Vaccines in Phase III, New Risk Calculators, and More

More vaccines enter Phase III trials, researchers continue to learn about the long-term impacts of Covid-19, and risk calculation becomes increasingly difficult as the country reopens. Here’s your week in coronavirus news: Want to receive this weekly roundup and other coronavirus news? Sign up here!HeadlinesThe race for a vaccine continues at warp speedWhen it comes…

Details